Rafael Sádaba, jefe del Servicio de Cirugía Cardíaca del HUN, nombrado presidente de la sociedad europea de su especialidad

Sex Differences in Prognosis of Patients with Genetic Dilated Cardiomyopathy @JonesLab_KUL @neallakdawala @Dr_Pavia @_antocannata @fernidom @raafs_anne @jpocardio @NereMA @SikkingM @martijn_hoes #AHAJournals https://t.co/WULgBOXmDD

📰 Los genes asociados a muerte súbita elevan el riesgo de insuficiencia cardíaca en pacientes con miocardiopatía dilatada genética. Un nuevo estudio en el que ha participado nuestro compañero @jpocardio, ha demostrado que algunas alteraciones genéticas asociadas a la

⏰ Just days left! Global leaders & KOLs live on HCM, amyloidosis & Fabry. In a few years you’ll ask why you missed this congress😉#HCM #Amyloidosis #Fabry

Teamwork made this study possible 🙌 Thanks to all my co-authors 👥 @esthglez @fernidom @cleaglez21 and especially to @dr_pavia for leading the project 👨‍⚕️🧬

📖 Full open-access article in JACC: CardioOncology @JACCJournals: 👉 https://t.co/fH3HKhEiWx

💡 Take-home message: Systematic cascade genetic screening in ATTRv families: 🧬 Identifies a median of 2 carriers per proband ❤️ Enables earlier diagnosis & treatment 👨‍👩‍👧 Provides counselling, reproductive planning & support

⚠️ Still, 1 in 3 relatives did not undergo genetic screening. Independent predictors of absence of testing: 👴 Older age 🌍 Living in a different province/country 🧑 Male sex 👨‍👩‍👦 Distant family relationship We must bridge these gaps.

⏱️ Earlier diagnosis & treatment Affected relatives were diagnosed and started disease-modifying therapy ~10 years earlier than probands (53 vs 66 years and 56.5 vs 66 years, both p<0.001). 📈🧬❤️ Timing matters!

📊 Study population (2010–2023, @cardiopdh): 👨‍👩‍👧 749 at-risk relatives from 86 families 🧬464 relatives studied (5/family) 👉263 non-carriers discharged 👉201 carriers (2/family) 🧬 🔹134 healthy genetic carriers (🧬🤰 in 7 relatives) 🔹67 (33%) with ATTRv manifestations(❤️🧠👁️)

🚨 Excited to share our latest work! “Impact of Genetic Testing & Family Screening in Hereditary Transthyretin Amyloidosis” 🧬❤️ Cascade genetic screening in ATTRv families 👨‍👩‍👧 enables earlier diagnosis, treatment & counselling. Here’s what we found 👇🧵

.@CNIC_CARDIO Genes linked to sudden cardiac death increase the risk of heart failure in patients with genetic dilated cardiomyopathy https://t.co/FIHJSTbEvb

💡 A Spanish study published lead Pablo García-Pavía @dr_pavia and Fernando Domínguez @fernidom published in @ehj_ed and presented at the @escardio (ESC) conference in #Madrid shows that patients with genetic dilated cardiomyopathy who experience severe arrhythmias are at an

Myocardial News Special Episode for the ESC 2025 congress is now available! #CardioTwitter #ESC2025

#ESCCongress | time to put the badge down! This was a special one 💛Madrid 🇪🇸 was 🔝 set and it was great to host my 🇵🇹 friends So many 🔝 points: my #SoMe ambassador role, our unit @cardiopdh on 🔥 with 🔝 science and major #LBT! Great networking with mentors and friends 💛❤️

🚨!! Just out in #EHJ and presented by @NereMA at #ESCCongress in Madrid @escardio @ESC_Journals

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure. Discover more in #EHJ #ESCCongress @escardio @ESC_Journals #genetics #heartfailure https://t.co/GZJqFceyl7

🚨 Live from #ESCCongress + now online in @CircAHA 🚨 https://t.co/KPsILAhJVT Honored to present our work on Intermediate-Effect Variants (IEVs) in HCM, selected for the Young Investigator Award. 🏆 60% of HCM cases G (-). Maybe we’ve been looking in the wrong place… 👇🧵

Already missing my #Car_Family

I am very grateful to all my mentors @dr_pavia @esthglez @fernidom @jpocardio and to all the fellows who shared this journey with me @peiro_belen @Eva_Ce_Erre @fdefrutossemi @MSBBrandao #Dani #Clea